BACKGROUND: Improving patients' quality of life is a primary indication for percutaneous coronary intervention (PCI), yet little is known about patient characteristics associated with greater quality-of-life improvement from the procedure. This study was conducted to identify patient characteristics associated with quality-of-life benefit after PCI. METHODS AND RESULTS: A consecutive series of 1518 patients undergoing PCI in nonacute myocardial infarction settings were prospectively enrolled into an observational study documenting their postprocedural health status. We examined univariate and multivariable associations between baseline patient characteristics and quality of life 1 year after the procedure using the disease-specific Seattle Angina Questionnaire (SAQ) to quantify the impact of patients' coronary disease on their quality of life. Baseline angina frequency and physical function were the strongest predictors of quality-of-life improvement 1 year after PCI. In comparing patients without angina to those experiencing monthly, weekly, and daily angina, the quality-of-life improvements (mean+/-SEM) were 21.4+/-2.1, 30.7+/-2.2, and 34.6+/-2.6 points greater (P<0.001). Patients with mild, moderate, and severe physical limitation improved 13.8+/-1.9, 20.0+/-2.1, and 13.5+/-3.5 points more than those with minimal baseline physical limitation (P<0.001). These findings were maintained in multivariable models correcting for baseline differences in demographic, clinical, disease-severity, and health-status variables. CONCLUSIONS: Preprocedural angina frequency is the most important prognostic indicator of quality-of-life improvement after PCI. Although substantial quality-of-life benefits are attained in most patients with preprocedural angina, more careful consideration of the potential benefits and risks of the procedure are needed in asymptomatic patients.
BACKGROUND: Improving patients' quality of life is a primary indication for percutaneous coronary intervention (PCI), yet little is known about patient characteristics associated with greater quality-of-life improvement from the procedure. This study was conducted to identify patient characteristics associated with quality-of-life benefit after PCI. METHODS AND RESULTS: A consecutive series of 1518 patients undergoing PCI in nonacute myocardial infarction settings were prospectively enrolled into an observational study documenting their postprocedural health status. We examined univariate and multivariable associations between baseline patient characteristics and quality of life 1 year after the procedure using the disease-specific Seattle Angina Questionnaire (SAQ) to quantify the impact of patients' coronary disease on their quality of life. Baseline angina frequency and physical function were the strongest predictors of quality-of-life improvement 1 year after PCI. In comparing patients without angina to those experiencing monthly, weekly, and daily angina, the quality-of-life improvements (mean+/-SEM) were 21.4+/-2.1, 30.7+/-2.2, and 34.6+/-2.6 points greater (P<0.001). Patients with mild, moderate, and severe physical limitation improved 13.8+/-1.9, 20.0+/-2.1, and 13.5+/-3.5 points more than those with minimal baseline physical limitation (P<0.001). These findings were maintained in multivariable models correcting for baseline differences in demographic, clinical, disease-severity, and health-status variables. CONCLUSIONS: Preprocedural angina frequency is the most important prognostic indicator of quality-of-life improvement after PCI. Although substantial quality-of-life benefits are attained in most patients with preprocedural angina, more careful consideration of the potential benefits and risks of the procedure are needed in asymptomatic patients.
Authors: S Michael Gharacholou; Veronique L Roger; Ryan J Lennon; Charanjit S Rihal; Jeff A Sloan; John A Spertus; Mandeep Singh Journal: Am J Cardiol Date: 2012-03-20 Impact factor: 2.778
Authors: Mohammed Qintar; Taishi Hirai; Suzanne V Arnold; Justin Sheehy; James Sapontis; Phil Jones; Yuanyuan Tang; William Lombardi; Dimitri Karmpaliotis; Jeffery Moses; Christian Patterson; William J Nicholson; David J Cohen; John A Spertus; J Aaron Grantham; Adam C Salisbury Journal: Am Heart J Date: 2019-04-26 Impact factor: 4.749
Authors: Kim G Smolderen; John A Spertus; Brahmajee K Nallamothu; Harlan M Krumholz; Fengming Tang; Joseph S Ross; Henry H Ting; Karen P Alexander; Saif S Rathore; Paul S Chan Journal: JAMA Date: 2010-04-14 Impact factor: 56.272
Authors: Anna Grodzinsky; Mikhail Kosiborod; Fengming Tang; Philip G Jones; Darren K McGuire; John A Spertus; John F Beltrame; Jae-Sik Jang; Abhinav Goyal; Neel M Butala; Robert W Yeh; Suzanne V Arnold Journal: Circ Cardiovasc Qual Outcomes Date: 2017-09